181 related articles for article (PubMed ID: 10589226)
1. [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs].
Knol A
Ned Tijdschr Geneeskd; 1999 Nov; 143(46):2339. PubMed ID: 10589226
[No Abstract] [Full Text] [Related]
2. [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs].
Salentijn GJ
Ned Tijdschr Geneeskd; 1999 Nov; 143(46):2340. PubMed ID: 10589227
[No Abstract] [Full Text] [Related]
3. [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs].
Steen KS; Lems WF; Dijkmans BA
Ned Tijdschr Geneeskd; 1999 Aug; 143(32):1649-52. PubMed ID: 10494299
[TBL] [Abstract][Full Text] [Related]
4. Complications of nonsteroidal antiiflammatory drug gastropathy and use of gastric cytoprotection: experience at a tertiary care health center.
Bakowsky VS; Hanly JG
J Rheumatol; 1999 Jul; 26(7):1557-63. PubMed ID: 10405945
[TBL] [Abstract][Full Text] [Related]
5. [Experience of treatment of patients with gastropathy induced by non-steroid anti-inflammatory drugs].
Vakhrushev IaM; Loshchakova OIu
Eksp Klin Gastroenterol; 2007; (1):60-3, 71. PubMed ID: 17547116
[TBL] [Abstract][Full Text] [Related]
6. Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.
Guslandi M
N Engl J Med; 1998 Jul; 339(5):350; author reply 350-1. PubMed ID: 9696651
[No Abstract] [Full Text] [Related]
7. Prophylaxis of nonsteroidal antiinflammatory drug gastropathy: a clinical opinion.
Roth SH; Fries JF; Abadi IA; Hubscher O; Mintz G; Samara AM
J Rheumatol; 1991 Jul; 18(7):956-8. PubMed ID: 1920327
[No Abstract] [Full Text] [Related]
8. Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.
Chan FK; Sung JJ
N Engl J Med; 1998 Jul; 339(5):349-50; author reply 350-1. PubMed ID: 9696650
[No Abstract] [Full Text] [Related]
9. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Goldstein JL; Huang B; Amer F; Christopoulos NG
Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
[TBL] [Abstract][Full Text] [Related]
10. Therapy for ulcers and erosions associated with nonsteroidal anti-inflammatory drugs.
Freeman HJ
Can J Gastroenterol; 1998; 12(8):537-9. PubMed ID: 10206732
[No Abstract] [Full Text] [Related]
11. Prophylaxis of NSAID gastropathy.
Roth SH
J Rheumatol; 1992 Apr; 19(4):662. PubMed ID: 1593593
[No Abstract] [Full Text] [Related]
12. There's the forest. The object lesson of NSAID "gastropathy".
Hadler NM
J Rheumatol; 1990 Mar; 17(3):280-2. PubMed ID: 2110251
[No Abstract] [Full Text] [Related]
13. The prevention of gastropathy and upper abdominal symptoms caused by nonsteroidal anti-inflammatory drugs.
Vakil N
Rev Gastroenterol Disord; 2006; 6(4):221-6. PubMed ID: 17224894
[TBL] [Abstract][Full Text] [Related]
14. [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs].
Houben JJ; Liem B
Ned Tijdschr Geneeskd; 1999 Nov; 143(46):2338. PubMed ID: 10589225
[No Abstract] [Full Text] [Related]
15. [Omeprazole and misoprostol for NSAID-induced gastropathies: comparative efficiency of their short-term treatment].
Karateev AE; Murav'ev IuV
Klin Med (Mosk); 2001; 79(5):48-50. PubMed ID: 11510188
[TBL] [Abstract][Full Text] [Related]
16. [The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs].
Fialová P; Vlcek J
Vnitr Lek; 2004 Nov; 50(11):858-66. PubMed ID: 15648967
[TBL] [Abstract][Full Text] [Related]
17. [NSAID-gastropathy: state-of-the-art therapy optimization capabilities in outpatient practice].
Burkov SG; Arutiunov AT; Gurova NIu; Lobanova EG; Nikiforov PA; Okoemov MN; Cherezova IN; Chugunnikova LI
Eksp Klin Gastroenterol; 2008; (3):97-101. PubMed ID: 19145889
[No Abstract] [Full Text] [Related]
18. [Prevention of ulcer lesions under non-steroid antirheumatic agents. For each patient the appropriate stomach protection].
MMW Fortschr Med; 2004 May; 146(22):48. PubMed ID: 15373113
[No Abstract] [Full Text] [Related]
19. [An open study on the efficacy and safety of misoprostol in prevention or treatment of gastroduodenal lesions induced by NSAID: preliminary data].
Passiu G
Clin Ter; 1991 Dec 15-31; 139(5-6):191-2. PubMed ID: 1802506
[No Abstract] [Full Text] [Related]
20. Healing and prevention of NSAID-associated ulcer disease: is seeing believing?
Fendrick AM; Scheiman JM
Am J Gastroenterol; 1998 Dec; 93(12):2628-9. PubMed ID: 9860450
[No Abstract] [Full Text] [Related]
[Next] [New Search]
